Phathom Pharmaceuticals Q1 2024 GAAP EPS $(1.42) Misses $(1.28) Estimate, Sales $1.912M Miss $2.047M Estimate
Phathom Pharmaceuticals Q1 2024 GAAP EPS $(1.42) Misses $(1.28) Estimate, Sales $1.912M Miss $2.047M Estimate
Phathom Pharmicals 2024年第一季度GAAP每股收益美元（1.42）未達到預期（1.28）美元，銷售額19.12萬美元低於20.47萬美元的預期
Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(1.42) per share which missed the analyst consensus estimate of $(1.28) by 10.94 percent. This is a 59.55 percent decrease over losses of $(0.89) per share from the same period last year. The company reported quarterly sales of $1.912 million which missed the analyst consensus estimate of $2.047 million by 6.61 percent.
Phathom Pharmicals（納斯達克股票代碼：PHAT）公佈的季度虧損爲每股1.42美元，比分析師普遍預期的1.28美元（1.28美元）低10.94％。與去年同期每股虧損0.89美元（0.89）相比，下降了59.55％。該公司公佈的季度銷售額爲19.12萬美元，比分析師普遍預期的20.47萬美元低6.61％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。